ISSUE #20 Jan 21, 2026
โœจNewly Launched Serviceโœจ
Instant access to media coverage about our company!
Korea's leading global biotech networking event, was held on Jan 14, 2026 (Wed) during the JP Morgan Healthcare Conference!
Even industry professionals who attend the event every year remarked that they had never seen such a crowd.
It reflects the noticeably growing global interest in Korean biotechnology๐ŸŒ๐Ÿค
๐ŸŒ KoreaBIO @JPM
๐Ÿš€ Korea Goes Global
โˆŽ How Korean Biopharmaceuticals Are Conquering the Global Market in 2026 - News1
โˆŽ K-Bio Targets the U.S. Market: Celltrion and Samsung Bioepis Close in on Originator Drugs - News1
โˆŽ ABL Bio seeks next license-out after GSK, Eli Lilly deals - The Korea Herald
โˆŽ Alteogen clinches $265m licensing deal with GSK subsidiary - The Korea Herald
โˆŽ Celltrion expands US market reach as Zymfentra and Inflectra secure major formulary listings - KBR
โˆŽ Korea's GCCL partners with OPIS to advance global clinical trial capabilitie - BioSpectrum Asia
โˆŽ Samsung Biologics expands Korea and US capacity, pursues CRDMO shift - Chosun Biz
โˆŽ Korea shapes global anti-aging market with new aesthetic procedures - Chosun Biz
โˆŽ Yuyu Pharma Establishes UCLA Office to Accelerate U.S. Pet Industry Expansion - The Korea Herald
๐Ÿ“ˆ Growth & Performance
โˆŽ K-Bio Challenges FDA's New Drug - IT Chosun
โˆŽ SK Bioscience launches new global R&D center in Incheon - Yonhap News Agency
โˆŽ ABL Bio's Dual-Target Anticancer Drug Clears FDA Hurdle - THE CHOSUN Daily
โˆŽ Samsung Bioepis Receives Domestic Approval for Epzutek Pen Formulation - The Asia Business Daily
โˆŽ Pharmaceutical Products Exports Reach $9.06 Billion in 2025, Up 14.1% - Newsmp
โˆŽ G.I. Innovation files patent application for next-generation dual-fusion pipeline in atopic dermatitis - THE BIO
โˆŽ Gangwon Province Strengthens Global Cooperation for K-Salmon Industrialization... Launches Localization of Atlantic Salmon - The Asia Business Daily
โˆŽ LG CNS invests in CHA Biotech to fast-track AI-powered digital health care - The Korea Times
โˆŽ NGeneBio Adopts LGโ€™s AI Model to Cut Diagnosis Time from 2 Weeks to 1 Minute - Business Korea
โˆŽ AI Precisely Predicts Optimal Timing for Atrial Fibrillation-Related Stroke Treatment... 87% Agreement with Specialists - The Asia Business Daily
๐Ÿ“ฐ
Join our press list
Get KoreaBIO updates
& media resources
๐Ÿ’ฌ
Share Your thoughts!
How was your letter today?
โœ‰๏ธ
Korean Newsletter
Daily biotech news from Korea and around the world
โ€” in Korean
Explore More
KoreaBIO (Korea Biotechnology Industry Organization)
700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea